Andrew W. Stacey

1.9k total citations
70 papers, 741 citations indexed

About

Andrew W. Stacey is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Andrew W. Stacey has authored 70 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Ophthalmology, 15 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Andrew W. Stacey's work include Ocular Oncology and Treatments (39 papers), Glaucoma and retinal disorders (12 papers) and Retinal Diseases and Treatments (10 papers). Andrew W. Stacey is often cited by papers focused on Ocular Oncology and Treatments (39 papers), Glaucoma and retinal disorders (12 papers) and Retinal Diseases and Treatments (10 papers). Andrew W. Stacey collaborates with scholars based in United States, United Kingdom and Israel. Andrew W. Stacey's co-authors include Ido Didi Fabian, Mandeep S. Sagoo, Craig N. Czyz, Mai Tsukikawa, M. Ashwin Reddy, Kenneth V. Cahill, Catriona Duncan, Tanzina Chowdhury, Dennis W. Stacey and Masahiro Hitomi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Andrew W. Stacey

62 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew W. Stacey United States 14 347 145 136 124 117 70 741
Neelam Pushker India 17 208 0.6× 324 2.2× 80 0.6× 140 1.1× 49 0.4× 84 898
Lingam Gopal India 20 764 2.2× 108 0.7× 139 1.0× 430 3.5× 164 1.4× 75 1.2k
Edward J. Wladis United States 20 382 1.1× 283 2.0× 96 0.7× 109 0.9× 80 0.7× 115 1.1k
Harsha Bhattacharjee India 15 488 1.4× 113 0.8× 22 0.2× 215 1.7× 53 0.5× 87 693
J. Lisa United States 22 644 1.9× 90 0.6× 168 1.2× 274 2.2× 109 0.9× 76 1.3k
Emad B. Abboud Saudi Arabia 20 787 2.3× 86 0.6× 35 0.3× 335 2.7× 235 2.0× 50 1.1k
David Chu United States 23 1.4k 3.9× 103 0.7× 39 0.3× 317 2.6× 123 1.1× 85 2.0k
Yujiro Fujino Japan 20 765 2.2× 73 0.5× 39 0.3× 114 0.9× 126 1.1× 68 1.1k
Tom Missotten Netherlands 17 750 2.2× 55 0.4× 59 0.4× 272 2.2× 167 1.4× 53 1.1k
Rex M. McCallum United States 15 468 1.3× 79 0.5× 38 0.3× 94 0.8× 130 1.1× 26 1.1k

Countries citing papers authored by Andrew W. Stacey

Since Specialization
Citations

This map shows the geographic impact of Andrew W. Stacey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Stacey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Stacey more than expected).

Fields of papers citing papers by Andrew W. Stacey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. Stacey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Stacey. The network helps show where Andrew W. Stacey may publish in the future.

Co-authorship network of co-authors of Andrew W. Stacey

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Stacey. A scholar is included among the top collaborators of Andrew W. Stacey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Stacey. Andrew W. Stacey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wallner, Kent, et al.. (2025). Simultaneous conjunctival melanomas in one eye treated with both adjuvant brachytherapy and proton beam radiotherapy. American Journal of Ophthalmology Case Reports. 38. 102281–102281.
3.
Beecher, Kate, Malcolm Lim, Andrew W. Stacey, et al.. (2024). B7-H3 Expression in Breast Cancer and Brain Metastasis. International Journal of Molecular Sciences. 25(7). 3976–3976. 9 indexed citations
4.
Stacey, Andrew W., Kazuo Nakamichi, Jeffrey Stevens, et al.. (2024). Prognostic importance of direct assignment of parent of origin via long-read genome and epigenome sequencing in retinoblastoma. JCI Insight. 10(4).
5.
Saini, Jatinder, Rajesh Regmi, Angela W.S. Fung, et al.. (2023). Improved lateral penumbra for proton ocular treatments on a general-purpose spot scanning beamline. Physica Medica. 107. 102551–102551. 4 indexed citations
6.
Stacey, Andrew W., Mai Tsukikawa, Ido Didi Fabian, et al.. (2020). Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. British Journal of Ophthalmology. 105(11). 1599–1603. 1 indexed citations
7.
Stacey, Andrew W., et al.. (2020). External Beam Radiotherapy vs Plaque Brachytherapy in Treatment of Uveal Melanoma: A Cost Analysis. Investigative Ophthalmology & Visual Science. 61(7). 3618–3618. 1 indexed citations
8.
Tsukikawa, Mai & Andrew W. Stacey. (2020). <p>A Review of Hypertensive Retinopathy and Chorioretinopathy</p>. Clinical Optometry. Volume 12. 67–73. 48 indexed citations
9.
Stacey, Andrew W., et al.. (2020). Progressive Preretinal Fibrosis with Late, Ossifying, Proliferative Retinopathy following Treatment for Retinoblastoma. Ocular Oncology and Pathology. 7(1). 44–47. 1 indexed citations
10.
Stacey, Andrew W., et al.. (2020). The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy. Ophthalmology Retina. 5(8). 824–830. 5 indexed citations
11.
Steineck, Angela, Niklas Krumm, Jay F. Sarthy, et al.. (2019). Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma. JCO Precision Oncology. 3(3). 1–6. 9 indexed citations
12.
Fabian, Ido Didi, Andrew W. Stacey, Tanzina Chowdhury, et al.. (2017). Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes. American Journal of Ophthalmology. 179. 137–144. 23 indexed citations
13.
Cabrera, Michelle T., et al.. (2017). Rapidly Progressive, Isolated Subretinal Leukemic Relapse: A Case Report. Ocular Oncology and Pathology. 4(4). 220–224. 5 indexed citations
14.
Stacey, Andrew W. & Hakan Demirci. (2016). Serial Intravitreal Bevacizumab Injections Slow the Progression of Radiation Maculopathy Following Iodine-125 Plaque Radiotherapy. The Open Ophthalmology Journal. 10(1). 103–110. 10 indexed citations
15.
Fabian, Ido Didi, Andrew W. Stacey, Kenneth P. Johnson, et al.. (2016). Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis. British Journal of Ophthalmology. 101(1). 82–88. 30 indexed citations
16.
Stacey, Andrew W., Joseph J. Gemmete, & Alon Kahana. (2015). Management of Orbital and Periocular Vascular Anomalies. Ophthalmic Plastic and Reconstructive Surgery. 31(6). 427–436. 25 indexed citations
17.
Stacey, Andrew W., et al.. (2015). A 6-year-old boy with Cornelia de Lange syndrome and Coats disease: case report and review of the literature. Journal of American Association for Pediatric Ophthalmology and Strabismus. 19(5). 474–478. 4 indexed citations
18.
Stacey, Andrew W., et al.. (2014). Risk of Ocular Blood Splatter During Oculofacial Plastic Surgery. Ophthalmic Plastic and Reconstructive Surgery. 31(3). 182–186. 1 indexed citations
19.
Davis, Stephen, et al.. (2013). A simple model for the establishment of tick-borne pathogens of Ixodes scapularis: A global sensitivity analysis of R0. Journal of Theoretical Biology. 335. 213–221. 1 indexed citations
20.
Dolman, Peter J., Kenneth V. Cahill, Craig N. Czyz, et al.. (2011). Reliability of Estimating Ductions in Thyroid Eye Disease. Ophthalmology. 119(2). 382–389. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026